NCT05392075View on ClinicalTrials.gov

COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

March 15, 2023

Study Completion Date

August 17, 2023

Conditions
COVID-19 PneumoniaCOVID-19
Interventions
BIOLOGICAL

Pfizer COVID-19 mRNA vaccine

vaccinated people who received the Pfizer COVID-19 mRNA vaccine

BIOLOGICAL

Moderna COVID-19 mRNA vaccine

vaccinated people who received the Moderna COVID-19 mRNA vaccine vaccine

Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER